The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below:
2nd Cancer Markers & Liquid Biopsies:
The role of cancer markers is significant towards the diagnosis, prognosis, and surveillance of a patient. Understanding markers and characterizing circulating elements with the latest technologies aid our progress toward the future of better personalized cancer care. Leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. This meeting will also discuss biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life.
There is a huge drive in Precision Medicine as it integrates research and clinical practice to build a knowledge base that can better guide individualized patient care. At a crucial time, where there are efforts to scale up population-based genome sequencing and integrate it with clinical data, this meeting will discuss the progress towards the implementation of precision medicine. This conference will discuss the future of healthcare, strategies and technologies for successful implementation, precision medicine beyond oncology, integrating and interpreting personal genomics, big data, bioinformatics, and overcoming challenges in the commercialization of precision medicine.
Digital PCR & qPCR:
There has been a push to find a faster and a more efficient way to optimize the quantification of nucleic acids. In the past, quantitative polymerase chain reaction (qPCR) has been the best way to measure the relative amplification of PCR in real time. In more recent years, digital PCR has become a newer method of PCR quantification that can result in absolute quantification, increased sensitivity in samples, more controllable precision, and multiple partitions of the same sample. This meeting will discuss the newest developments in digital PCR and qPCR in relation to how PCR can be used the molecular diagnostics field.